Our flow cytometry‐based immune cell profiling included the quantitation of CD4+/CD8+ effector T cell ratios, exhaustion of CD8+ T cells, myeloid‐derived suppressor cells (MDSC), and tumor‐associated macrophages. The gene discussed is CD4; the disease is neoplasm.